This book examines policy issues in synthetic biology including R&D funding, company investment, PPP arrangements and innovative financing, infrastructure requirements, education and training, intellectual property (IP), regulation, and public engagement.
This site is powered by Keepeek 360, Logiciel de DAM for business.
|Link to this publication:|
|Link to this publication with cover:|
|Link to this page:|